These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 19524584)
21. Neuroactive steroids: an update of their roles in central and peripheral nervous system. Melcangi RC; Panzica G Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S1-8. PubMed ID: 19954893 [TBL] [Abstract][Full Text] [Related]
22. Sex hormones, central nervous system and pain. Aloisi AM; Bonifazi M Horm Behav; 2006 Jun; 50(1):1-7. PubMed ID: 16423353 [TBL] [Abstract][Full Text] [Related]
26. Neuroprotective actions of sex steroids in Parkinson's disease. Bourque M; Dluzen DE; Di Paolo T Front Neuroendocrinol; 2009 Jul; 30(2):142-57. PubMed ID: 19410597 [TBL] [Abstract][Full Text] [Related]
27. Perfusion magnetic resonance imaging in psychiatry. Théberge J Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433 [TBL] [Abstract][Full Text] [Related]
28. Neurosteroids and neuroactive drugs in mental disorders. Pisu MG; Serra M Life Sci; 2004 May; 74(26):3181-97. PubMed ID: 15094320 [TBL] [Abstract][Full Text] [Related]
29. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Papadopoulos V; Lecanu L; Brown RC; Han Z; Yao ZX Neuroscience; 2006; 138(3):749-56. PubMed ID: 16338086 [TBL] [Abstract][Full Text] [Related]
30. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Barchet TM; Amiji MM Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842 [TBL] [Abstract][Full Text] [Related]
31. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Schumacher M; Guennoun R; Stein DG; De Nicola AF Pharmacol Ther; 2007 Oct; 116(1):77-106. PubMed ID: 17659348 [TBL] [Abstract][Full Text] [Related]
32. The Role of Sex and Sex Hormones in Neurodegenerative Diseases. Vegeto E; Villa A; Della Torre S; Crippa V; Rusmini P; Cristofani R; Galbiati M; Maggi A; Poletti A Endocr Rev; 2020 Apr; 41(2):273-319. PubMed ID: 31544208 [TBL] [Abstract][Full Text] [Related]
34. Neuroactive steroids: old players in a new game. Melcangi RC; Panzica GC Neuroscience; 2006; 138(3):733-9. PubMed ID: 16343786 [TBL] [Abstract][Full Text] [Related]
35. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
36. New steps forward in the neuroactive steroid field. Giatti S; Garcia-Segura LM; Melcangi RC J Steroid Biochem Mol Biol; 2015 Sep; 153():127-34. PubMed ID: 25797031 [TBL] [Abstract][Full Text] [Related]
37. Recent developments in the significance and therapeutic relevance of neuroactive steroids--Introduction to the special issue. Morrow AL Pharmacol Ther; 2007 Oct; 116(1):1-6. PubMed ID: 17531324 [TBL] [Abstract][Full Text] [Related]
38. Steroid hormones and BDNF. Pluchino N; Russo M; Santoro AN; Litta P; Cela V; Genazzani AR Neuroscience; 2013 Jun; 239():271-9. PubMed ID: 23380505 [TBL] [Abstract][Full Text] [Related]
39. Inflammation in the nervous system--physiological and pathophysiological aspects. Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167 [TBL] [Abstract][Full Text] [Related]
40. Ubiquitin proteasome system as a pharmacological target in neurodegeneration. Hol EM; Fischer DF; Ovaa H; Scheper W Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]